Eric Bjerholt, CFO of Mirum Pharmaceuticals ($MIRM), sold shares on the open market four times in the last year, totaling nearly $962,000. His most recent sale occurred on January 26, 2026. These transactions rank him 5,024th among 11,678 insiders by sale value, below the average of $8.6 million per insider and 6.4 transactions. Bjerholt made no open market purchases in this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 15, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | M | Performance Restricted Stock Units | 13334 | $0.00 | 6,666.0000 | 56,993,841 | 66.67% | 0.02% |
| March 15, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | M | Common Stock | 13334 | $0.00 | 57,075.0000 | 56,993,841 | 30.48% | 0.02% |
| March 16, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | S | Common Stock | 7287 | $91.98 | 49,788.0000 | 56,993,841 | 12.77% | 0.01% |
| Jan. 28, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 18140 | $0.00 | 18,140.0000 | 56,993,841 | 9999.99% | 0.03% |
| Jan. 28, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | A | Performance Restricted Stock Units | 20000 | $0.00 | 20,000.0000 | 56,993,841 | 9999.99% | 0.04% |
| Jan. 28, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | A | Restricted Stock Units | 11760 | $0.00 | 11,760.0000 | 56,993,841 | 9999.99% | 0.02% |
| Jan. 23, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 2667 | $0.00 | 2,666.0000 | 56,993,841 | 50.01% | 0.00% |
| Jan. 23, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | M | Common Stock | 2667 | $0.00 | 44,794.0000 | 56,993,841 | 6.33% | 0.00% |
| Jan. 26, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | S | Common Stock | 1053 | $96.19 | 43,741.0000 | 56,993,841 | 2.35% | 0.00% |
| Jan. 21, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | M | Common Stock | 3334 | $0.00 | 43,548.0000 | 56,993,841 | 8.29% | 0.01% |
| Jan. 22, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | S | Common Stock | 1421 | $93.33 | 42,127.0000 | 56,993,841 | 3.26% | 0.00% |
| Jan. 21, 2026 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 3334 | $0.00 | 6,666.0000 | 56,993,841 | 33.34% | 0.01% |
| Sept. 11, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | M | Common Stock | 18333 | $0.00 | 49,523.0000 | 47,522,594 | 58.78% | 0.04% |
| Sept. 11, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 18333 | $0.00 | 18,333.0000 | 47,522,594 | 50.00% | 0.04% |
| Sept. 12, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | S | Common Stock | 9578 | $76.01 | 39,945.0000 | 47,522,594 | 19.34% | 0.02% |
| Aug. 11, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | S | Common Stock | 8000 | $0.00 | 28,236.0000 | 47,522,594 | 22.08% | 0.02% |
| Aug. 12, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | M | Employee Stock Option (right to buy) | 2954 | $0.00 | 29,046.0000 | 47,522,594 | 9.23% | 0.01% |
| Aug. 12, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | M | Common Stock | 2954 | $26.49 | 31,190.0000 | 47,522,594 | 10.46% | 0.01% |
| June 10, 2025 | Metagenomi Therapeutics, Inc. | $MGX | BJERKHOLT ERIC | Not found | A | Stock Option (Right to Buy) | 8572 | $0.00 | 8,572.0000 | 1,870,923 | 9999.99% | 0.46% |
| June 3, 2025 | CERUS CORP | $CERS | BJERKHOLT ERIC | Not found | A | Common Stock | 60000 | $0.00 | 222,133.0000 | 185,789,815 | 37.01% | 0.03% |
| May 14, 2025 | Surrozen, Inc./DE | $SRZN | BJERKHOLT ERIC | Not found | A | Option (right to buy) | 1333 | $0.00 | 1,333.0000 | 3,281,169 | 9999.99% | 0.04% |
| Feb. 3, 2025 | Metagenomi Therapeutics, Inc. | $MGX | BJERKHOLT ERIC | Not found | A | Stock Option (Right to Buy) | 42000 | $0.00 | 42,000.0000 | 1,870,923 | 9999.99% | 2.24% |
| Jan. 23, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 2667 | $0.00 | 5,333.0000 | 47,522,594 | 33.34% | 0.01% |
| Jan. 23, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | M | Common Stock | 2667 | $0.00 | 35,946.0000 | 47,522,594 | 8.01% | 0.01% |
| Jan. 21, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | A | Restricted Stock Units | 10000 | $0.00 | 10,000.0000 | 47,522,594 | 9999.99% | 0.02% |
| Jan. 21, 2025 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 47,522,594 | 9999.99% | 0.08% |
| Dec. 12, 2024 | CERUS CORP | $CERS | BJERKHOLT ERIC | Not found | S | Common Stock | 20000 | $1.79 | 162,133.0000 | 0 | 10.98% | 0.00% |
| Nov. 8, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | A | Common Stock | 475 | $21.05 | 33,279.0000 | 47,782,619 | 1.45% | 0.00% |
| Sept. 11, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | M | Restricted Stock Units | 18334 | $0.00 | 36,666.0000 | 40,885,124 | 33.33% | 0.04% |
| Sept. 11, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | M | Common Stock | 18334 | $0.00 | 32,804.0000 | 40,885,124 | 126.70% | 0.04% |
| Aug. 27, 2024 | CalciMedica, Inc. | $CALC | BJERKHOLT ERIC | Not found | A | Director Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 4,486,258 | 9999.99% | 0.22% |
| June 5, 2024 | CERUS CORP | $CERS | BJERKHOLT ERIC | Director | A | Common Stock | 40000 | $5.00 | 182,133.0000 | 0 | 28.14% | 0.00% |
| June 5, 2024 | Surrozen, Inc./DE | $SRZN | BJERKHOLT ERIC | Not found | A | Option (right to buy) | 1333 | $0.00 | 1,333.0000 | 0 | 9999.99% | 0.00% |
| May 10, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | A | Common Stock | 470 | $21.05 | 14,470.0000 | 40,885,124 | 3.36% | 0.00% |
| March 28, 2024 | CalciMedica, Inc. | $CALC | BJERKHOLT ERIC | Not found | A | Director Stock Option (Right to Buy) | 10000 | $0.00 | 10,000.0000 | 4,486,258 | 9999.99% | 0.22% |
| March 27, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | P | Common Stock | 2000 | $24.80 | 14,000.0000 | 40,885,124 | 16.67% | 0.00% |
| March 18, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | P | Common Stock | 2000 | $25.80 | 12,000.0000 | 40,885,124 | 20.00% | 0.00% |
| Jan. 23, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | A | Restricted Stock Units | 8000 | $0.00 | 8,000.0000 | 40,885,124 | 9999.99% | 0.02% |
| Jan. 23, 2024 | Mirum Pharmaceuticals, Inc. | $MIRM | BJERKHOLT ERIC | CHIEF FINANCIAL OFFICER | A | Stock Option (right to buy) | 32000 | $0.00 | 32,000.0000 | 40,885,124 | 9999.99% | 0.08% |
| Dec. 13, 2023 | CERUS CORP | $CERS | BJERKHOLT ERIC | Director | P | Common Stock | 10000 | $1.62 | 142,133.0000 | 0 | 7.57% | 0.00% |
| Aug. 21, 2023 | CERUS CORP | $CERS | BJERKHOLT ERIC | Director | P | Common Stock | 10000 | $1.72 | 132,133.0000 | 0 | 8.19% | 0.00% |
| June 7, 2023 | CERUS CORP | $CERS | BJERKHOLT ERIC | Director | A | Common Stock | 40000 | $5.00 | 122,133.0000 | 0 | 48.70% | 0.00% |
| May 23, 2023 | CERUS CORP | $CERS | BJERKHOLT ERIC | Director | P | Common Stock | 5000 | $2.00 | 82,133.0000 | 0 | 6.48% | 0.00% |
| May 18, 2023 | Surrozen, Inc./DE | $SRZN | BJERKHOLT ERIC | Not found | A | Option (right to buy) | 20000 | $0.00 | 20,000.0000 | 0 | 9999.99% | 0.00% |